Cellosaurus cell line 153.8E2.D10.D6.12.12 (CVCL

Cross-references
Cell line name	153.8E2.D10.D6.12.12
Synonyms	153.8E2D10D6.12.12; 12.12; CHIR-12.12
Accession	CVCL_J992
Resource Identification Initiative	To cite this cell line use: 153.8E2.D10.D6.12.12 (RRID:CVCL_J992)
Comments	Group: Patented cell line. Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5543. Registration: Chiron Master Culture Collection; CMCC 12056 (CMCC #12056). Monoclonal antibody isotype: IgG1, kappa. Monoclonal antibody target: UniProtKB; P25942; Human CD40.
Species of origin	Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Hierarchy	Parent: CVCL_2199 (Sp2/0-Ag14)
Category	Hybridoma
Publications	Patent=US20070098718 Long L., Luqman M., Yabannavar A., Zaror I. Methods of therapy for B cell-related cancers. Patent number US20070098718, 03-May-2007 Patent=US20070218060 Long L., Luqman M., Yabannavar A., Zaror I. Use of antagonist anti-CD40 monoclonal antibodies for treatment of multiple myeloma. Patent number US20070218060, 20-Sep-2007 Patent=US8333970 Aukerman S.L., Jallal B., Luqman M. Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject having an inflammatory or autoimmune disease. Patent number US8333970, 18-Dec-2012
Cell line collections (Providers)	ATCC; PTA-5543
Biological sample resources	ABCD; ABCD_AC977
Encyclopedic resources	Wikidata; Q54582075
Entry history
Entry creation	11-Feb-2013
Last entry update	21-Mar-2023
Version number	8